ArticleImmunity2025

Tumor-derived arachidonic acid reprograms neutrophils to promote immune suppression and therapy resistance in triple-negative breast cancer.

Liqun Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.